Electronic Beat For Medical Devices

Biotronik Partners With Acutus Medical to Offer More Efficient Arrhythmia Diagnosis and Treatment May 20, 2020 — Acutus Medical and Biotronik announced a new alliance to provide a comprehensive portfolio of electrophysiology, mapping, ablation and accessory products for catheter-based treatment of cardiac arrhythmias across select markets, including Europe and Asia.

https://www.prnewswire.com/news-releases/fda-approves-biotroniks-ultrathin-orsiro-stent-for-the-treatment-of-coronary-artery-disease-300800442.html

FDA Approves BIOTRONIK's Ultrathin Orsiro Stent for the Treatment of Coronary Artery Disease LAKE OSWEGO, Ore., Feb. 22, 2019 /PRNewswire/ -- BIOTRONIK today announced FDA approval of the Orsiro drug-eluting stent (DES) system. Orsiro is the first and...

Polymer-Free BioFreedom Stent as Safe as Orsiro, but Not as Effective Experts were reassured by the safety of the device and want to see polymer-free BioFreedom stent tested in high-bleeding-risk patients.

TCT Congress 2018: BIOTRONIK's Orsiro Ultrathin Drug-Eluting Stent Further Outperforms Xience at Two-Year Follow-Up

TCT Congress 2018: BIOTRONIK's Orsiro Ultrathin Drug-Eluting Stent Further Outperforms Xience at Two-Year Follow-Up Randomized Controlled Trial Data Presented at TCT Continues to Show Significantly Lower Event Rates with Orsiro in the BIOFLOW-V Trial

ESC Congress 2017: BIOTRONIK's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial | Markets Insider BARCELONA, Spain, Aug. 28, 2017 /PRNewswire/ -- BIOTRONIK today announced data from the BIOFLOW-V randomized trial comparing Orsiro* and Xience** drug-eluti...